Format

Send to

Choose Destination
Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S59-62. Epub 2011 Oct 21.

Glucocorticoids in rheumatoid arthritis: lessons from the Utrecht study.

Author information

1
Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands. j.w.g.jacobs@azu.nl

Abstract

The lessons from the Utrecht study on glucocorticoid therapy in early rheumatoid arthritis and of the spin-off and follow-up studies are reviewed. The data indicate that: glucocorticoids are DMARDs, the joint-sparing effect is predominantly on erosions, glucocorticoids do not influence the percentage of patients developing erosive disease, and the gain in joint-sparing effect persists after the stop of treatment. Further lessons are that the size of the joint-sparing effect and the (presumed) size of the symptomatic effect of glucocorticoids depend on co-therapies. Additional DMARDs must be added to glucocorticoids for maximum effect on radiographic progression. Finally, low-dose glucocorticoids are safer than often thought.

PMID:
22018185
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Clinical and Experimental Rheumatology
Loading ...
Support Center